Curavit

Curavit is a leader in the design and execution of decentralized clinical trials, with the slogan "Curavit is a Leader in the Design and Execution of Decentralized Clinical Trials." Founded in 2019 and headquartered in the United States, Curavit is the "First All-Virtual CRO," specializing in the design and execution of decentralized or "virtual" clinical trials. By leveraging emerging technologies in digital health, cloud computing, and data science, Curavit is able to recruit, engage, and monitor diverse patient populations from anywhere, eliminating the need for physical infrastructure and travel, thus increasing data quality. The company brings together leading researchers, enrolls previously untapped and underserved patient populations, and applies machine learning algorithms to health and social engagement information to recruit participants. The $5.00M Series A investment received on 14 November 2022 from investors including Osage Venture Partners, Royal Street Ventures, Narrow Gauge Ventures, Matt Wallach, and Clark Golestani demonstrates the market's confidence in Curavit's innovative approach to revolutionizing clinical trials within the Health Care and Pharmaceutical industries. With a central virtual site that supports remote monitoring and is always audit-ready, Curavit is poised to continue making significant strides in the field of decentralized clinical trials.